Alexion Pharmaceuticals welcomes new board member from data and analytics company
February 5, 2018Alexion Pharmaceuticals has adde Judith A. Reinsdorf to its Board of Directors.
Reinsdorf until recently served as Executive Vice President and General Counsel of Johnson Controls International, a global leader in building products and technology, integrated solutions, and energy storage, following its merger in September 2016 with Tyco International, where she served as Executive Vice President and General Counsel from March 2007 until September 2016.
Reinsdorf currently serves on the Board of Directors of Dun & Bradstreet, a publicly traded data and analytics company.
Reinsdorf added: “I am excited to join Alexion’s Board of Directors at a pivotal time for the Company as it executes on a strategy to deliver sustainable growth and strengthens its leadership position in rare diseases. I look forward to applying my experience to help guide Alexion’s future success.”
